September 6, 2016

Sanofi Board of Directors Provides Update

 

Sanofi Board of Directors Provides Update

Paris, France – September 6, 2016 Sanofi’s Board of Directors was informed by Bonnie L. Bassler that she wished to resign as a Director of Sanofi due to a potential conflict of interest related to her impending membership on another board. Accordingly, her resignation was accepted, effective September 6th.

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi is organized into five global business units: Diabetes and Cardiovascular, General Medicines and Emerging Markets, Sanofi Genzyme, Sanofi Pasteur and Merial. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).​